The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis by Ki-67 and baseline CgA of the randomized, placebo-controlled phase 3 study of surufatinib in advanced well-differentiated pancreatic neuroendocrine tumors (SANET-p).
 
Xianjun Yu
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Jie Li
No Relationships to Disclose
 
Zhiwei Zhou
No Relationships to Disclose
 
Zhiping Li
No Relationships to Disclose
 
Enxiao LI
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Yihebali Chi
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Wenhui Lou
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Dianrong Xiu
No Relationships to Disclose
 
Xiuwen Wang
No Relationships to Disclose
 
Sha Guan
Employment - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma
 
Qian Xu
Employment - Hutchison MediPharma
 
Weiguo Su
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma